SARS-CoV-2 NAAT (POCT)
Tests:SARS-Cov-2 NAAT (POCT)
\
Overview | |
|---|---|
| Department | Point of Care (POCT) |
| Test Code | N/A |
| Synonyms | COVID-19, SARS-CoV-2, Novel Coronavirus, ID NOW - cCOVID |
| Availability | Only available at Taranaki Base ED and Hawera ED |
| Turnaround Time | Once Patients sample has been placed on the analyser, results can be obtained no longer than 15 minutes |
| Stability – Add test | Dry swab sample must be processed ASAP |
Specimen Requirements | |
| Specimen | Nasal or Nasopharyngeal swab |
| Preferred | Nasopharyngeal swab |
| Acceptable | Only sample taken with dry swab included in the ID NOW test kits. |
| Unacceptable | Any other swabs not as part of the testing kit |
| Specimen Transportation | Room temperature/ambient and ASAP to the analyser for processing |
Test Information | |
| Test Method | ID NOW - COVID 19 (ABBOTT)
Real-time isothermal Nucleic Acid Amplification Test (NAAT) |
| Units of Measurement | Qualitative |
| Reference Intervals | Results, reported as SARS-CoV-2 POCT NAAT either as - DETECTED or NOT Detected.
No Ct values are available for this test |
| uncertainty of Measurement | N/A |
| Additional Informationm | To minimise inhibition in the testing, please ensure the patients' blow their nose prior to taking either Nasal or Nasopharyngeal swab.
Specimens that fail for technical reasons can be tested by another platform in the Laboratory. A repeat sample is to be requested using a QUAD swab (VTM swab) |
Comments | |
| Please note that a negative SARS-CoV-2 point-of-care test may not fully exclude COVID-19 infection. A second sample for repeat POC or laboratory PCR can be considered if there is a high clinical suspicion of infection. | |
| Owner | Pam Chung (Pchung) |
|---|---|
| Last reviewed | 2 Oct 2025 |
| Next review | Overdue, 2 Oct 2026 |